Copyright
©The Author(s) 2025.
World J Gastroenterol. Jul 14, 2025; 31(26): 105656
Published online Jul 14, 2025. doi: 10.3748/wjg.v31.i26.105656
Published online Jul 14, 2025. doi: 10.3748/wjg.v31.i26.105656
Figure 11 Kushenol I preserves the intestinal barrier and optimizes gut microbiota to combat ulcerative colitis.
AKT: Protein kinase B; CD: Cluster of differentiation; FOXO1: Forkhead box O1; GSH-PX: Glutathione peroxidase; IL: Interleukin; MDA: Malondialdehyde; MPO: Myeloperoxidase; NF-κB: Nuclear factor kappa B; NLRP3: NOD-like receptor thermal protein domain associated protein 3; PI3K: Phosphoinositide 3-kinase; SOD: Superoxide dismutase; TNF: Tumor necrosis factor; TLR4: Toll-like receptor 4; ZO-1: Zonula occludens-1.
- Citation: He XD, Li M, Zuo XD, Ni HY, Han YX, Hu YK, Yu J, Yang XX. Kushenol I combats ulcerative colitis via intestinal barrier preservation and gut microbiota optimization. World J Gastroenterol 2025; 31(26): 105656
- URL: https://www.wjgnet.com/1007-9327/full/v31/i26/105656.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i26.105656